Skip to content

What are the examples of Miotic drugs? A Guide to Cholinergic and Adrenergic Agents

4 min read

First used in eye care for over a century, miotic drugs cause the pupil to constrict, a process known as miosis, by affecting the eye's muscles. This pharmacological action, which can either stimulate the parasympathetic pathway or inhibit the sympathetic pathway, is leveraged to treat various eye conditions. A diverse range of miotic drug examples exists, each with a unique mechanism and application.

Quick Summary

Miotic drugs constrict the pupil by affecting the eye's muscles, primarily used for treating glaucoma and other eye conditions. Examples include cholinergic agonists like pilocarpine and carbachol, as well as indirect-acting anticholinesterases and adrenergic antagonists.

Key Points

  • Categorization: Miotic drugs are classified primarily as either direct-acting cholinergic agonists or indirect-acting anticholinesterase agents, both affecting the eye's parasympathetic system.

  • Pilocarpine: A well-known direct-acting miotic, pilocarpine is used for conditions like glaucoma and, in modern formulations (Vuity), for presbyopia to improve near vision.

  • Echothiophate: An example of a potent, long-acting indirect-acting miotic that irreversibly inhibits acetylcholinesterase, though its use is limited due to significant side effects like cataracts.

  • Surgical Miosis: Rapid miosis for ophthalmic surgery is achieved using intraocular injections of short-acting agents like acetylcholine (Miochol-E) or longer-lasting carbachol (Miostat).

  • Side Effects: Common side effects include headache, brow ache, and blurred vision, with stronger agents carrying a higher risk of serious complications like retinal detachment and systemic effects.

In This Article

What Are Miotic Drugs and How Do They Work?

Miotic drugs are a class of medications that cause pupillary constriction, or miosis. This is achieved by either stimulating the parasympathetic nervous system or inhibiting the sympathetic nervous system within the eye. This action leads to the contraction of the iris sphincter muscle, decreasing the size of the pupil. A constricted pupil can improve near vision through the "pinhole effect" and is a key therapeutic effect in treating conditions like glaucoma.

There are two primary pharmacological mechanisms through which miotic drugs operate:

  • Direct-acting cholinergic agonists: These agents mimic the action of acetylcholine, the neurotransmitter of the parasympathetic nervous system. By binding directly to muscarinic receptors on the iris sphincter and ciliary body, they cause the muscles to contract.
  • Indirect-acting anticholinesterases: These drugs inhibit the enzyme acetylcholinesterase, which is responsible for breaking down acetylcholine. This allows the body's own acetylcholine to accumulate at nerve endings, leading to prolonged and amplified effects on the iris and ciliary muscle.

Examples of Miotic Drugs

Examples of miotic drugs are categorized based on their mechanism of action:

Direct-Acting Cholinergic Agonists

  • Pilocarpine (brand names: Vuity, Isopto Carpine): This is one of the most well-known miotics. It is a stable, reliable drug that mimics acetylcholine to cause pupil and ciliary muscle contraction. In addition to its historical use for glaucoma, a low-concentration formulation (Vuity) has recently been approved for treating presbyopia by improving near vision. Side effects can include headache and blurred vision.
  • Carbachol (brand name: Miostat): Carbachol has a longer duration of action than pilocarpine but penetrates the cornea poorly, requiring a wetting agent for topical use. It is often used intracamerally (injected directly into the eye) during surgery, such as cataract extraction, to achieve rapid and prolonged miosis.
  • Acetylcholine (brand name: Miochol-E): The prototypical direct-acting cholinergic drug, acetylcholine is used exclusively for intraocular injection during surgery to produce rapid miosis. It is not effective as a topical treatment due to its rapid inactivation by cholinesterase.

Indirect-Acting Anticholinesterases

  • Echothiophate Iodide (brand name: Phospholine Iodide): This is a potent, long-acting anticholinesterase that irreversibly inhibits the breakdown of acetylcholine. It was historically used for glaucoma and accommodative esotropia but is now rarely prescribed due to significant side effects, including cataract formation and systemic toxicity risks.
  • Demecarium Bromide (brand name: Humorsol): A reversible, long-acting anticholinesterase, demecarium was used for glaucoma and esotropia but is no longer commercially available in the U.S.
  • Physostigmine: This is a reversible anticholinesterase that is rarely used topically for miotic purposes today because of its irritative nature and high potential for allergic reactions.

Adrenergic Antagonists (Alpha-2 Agonists)

  • Brimonidine (brand names: Alphagan, Lumify): While primarily used to lower intraocular pressure, brimonidine is an alpha-2 adrenergic receptor agonist that can also cause miosis by inhibiting the sympathetic pathway that dilates the pupil. It works by reducing the release of norepinephrine from nerve endings, relaxing the iris dilator muscle.

Therapeutic Applications of Miotic Drugs

Miotic drugs are prescribed for several ophthalmic conditions:

  • Glaucoma: Miotics, particularly older cholinergic agents like pilocarpine and carbachol, reduce intraocular pressure (IOP) by contracting the ciliary muscle. This action pulls on the trabecular meshwork, increasing the outflow of aqueous humor and relieving pressure. While once a first-line treatment, they are now often reserved for patients who do not respond to other medications.
  • Presbyopia: Recent developments have introduced low-dose pilocarpine formulations (Vuity) for age-related near vision loss. By constricting the pupil, these drops create a "pinhole effect" that increases the depth of focus, improving near vision.
  • Ocular Surgery: Rapid and precise miosis is required during certain anterior segment surgeries, such as cataract removal. Intracameral acetylcholine (Miochol-E) and carbachol (Miostat) are used to achieve this effect, preventing complications.
  • Accommodative Esotropia: In children with this type of inward-turning eye, miotics like echothiophate can be used to treat the condition.

Comparison of Common Miotic Drugs

Feature Pilocarpine Carbachol Acetylcholine Echothiophate Brimonidine (miotic effect)
Mechanism Direct-acting cholinergic agonist Direct-acting cholinergic agonist Direct-acting cholinergic agonist Indirect-acting anticholinesterase Alpha-2 adrenergic agonist
Route Ophthalmic drops, gel, oral tablets Ophthalmic drops (with wetting agent), intraocular injection Intraocular injection Ophthalmic drops Ophthalmic drops
Duration 4 to 6 hours Longer than pilocarpine (up to 24 hours for injected form) Very short (seconds) Long-acting (days to weeks) Several hours
Primary Uses Glaucoma, Presbyopia, Dry Mouth Surgical miosis, Glaucoma (older use) Surgical miosis Glaucoma (rarely), Esotropia Lowering IOP (has miotic side effect)
Notable Most common miotic. Vuity used for presbyopia. Used for surgical purposes. Poor corneal absorption for drops. Very rapid, short action for surgery. Irreversible action, associated with cataracts and systemic side effects. Inhibits dilator muscle rather than contracting sphincter.

Potential Side Effects of Miotic Drugs

While effective, miotics are associated with various side effects, which tend to be more pronounced with stronger, longer-acting agents:

  • Ocular Side Effects: The most common effects are ciliary spasm, which can cause headache and brow ache, and blurred vision or induced myopia. Reduced vision in dim light, eye irritation, and redness are also frequent complaints. More serious, though rare, side effects include the formation of iris cysts and the risk of retinal detachment.
  • Systemic Side Effects: Systemic absorption, especially from stronger agents, can lead to side effects resulting from parasympathetic stimulation. These may include nausea, vomiting, diarrhea, sweating, and heart rate abnormalities. Proper administration techniques, such as nasolacrimal occlusion, help minimize systemic exposure.

Conclusion

Miotic drugs represent a diverse class of pharmacological agents with the common purpose of constricting the pupil. Their primary examples are cholinergic agonists like pilocarpine and carbachol, as well as anticholinesterases such as echothiophate. More recently, some adrenergic agonists like brimonidine have been noted for their miotic effects. These drugs are essential in treating a range of eye conditions, from reducing intraocular pressure in glaucoma to addressing presbyopia and facilitating ocular surgery. While historically significant, particularly for glaucoma, the emergence of alternative treatments and the potential for side effects have led to miotics being used more selectively in modern ophthalmology.

Frequently Asked Questions

The primary action of miotic drugs is to cause pupillary constriction, or miosis, which is achieved by causing the iris sphincter muscle to contract.

Low-dose pilocarpine treats presbyopia by constricting the pupil, creating a "pinhole effect" that increases the depth of focus and improves near vision.

Intraocular acetylcholine (Miochol-E) and carbachol (Miostat) are injected during eye surgery to cause rapid and prolonged miosis, which helps control intraocular pressure and reduces surgical complications.

Common side effects include headache, brow ache from ciliary muscle spasm, blurred or poor vision in dim light, and eye irritation.

Older miotics like echothiophate are used less frequently today due to the availability of newer, safer medications and the potential for severe side effects, including cataracts.

Yes, miotic drugs can cause a temporary myopic (nearsighted) shift due to ciliary muscle contraction, which can result in blurred distant vision, especially in younger patients.

Most miotics are cholinergic, either acting directly like pilocarpine or indirectly like echothiophate. However, adrenergic agonists like brimonidine also have a miotic effect by inhibiting the pupil's dilator muscle.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.